BACKGROUND: Stored red blood cells (RBCs) release hemoglobin (Hb) that leads to oxidative damage, which may contribute to thrombosis in susceptible transfusion recipients. Oxidative stress stimulates the generation of a new class of lipid mediators called F2 -isoprostanes (F2 -IsoPs) and isofurans (IsoFs) that influence cellular behavior. This study investigated RBC-derived F2 -IsoPs and IsoFs during storage and their influence on human platelets (PLTs). STUDY DESIGN AND METHODS: F2 -IsoP and IsoF levels in RBC supernatants were measured by mass spectrometry during storage and after washing. The effects of stored supernatants, cell-free Hb, or a key F2 -IsoP, 8-iso-prostaglandin F2α (PGF2α ), on PLT function were examined in vitro. RESULTS: F2 -IsoPs, IsoFs, and Hb accumulated in stored RBC supernatants. Prestorage leukoreduction reduced supernatant F2 -IsoPs and IsoFs levels, which increased again over storage time. Stored RBC supernatants and 8-iso-PGF2α induced PLT activation marker CD62P (P-selectin) expression and prothrombotic thromboxane A2 release. Cell-free Hb did not alter PLT mediator release, but did inhibit PLT spreading. Poststorage RBC washing reduced F2 -IsoP and IsoF levels up to 24 hours. CONCLUSIONS: F2 -IsoPs and IsoFs are produced by stored RBCs and induce adverse effects on PLT function in vitro, supporting a potential novel role for bioactive lipids in adverse transfusion outcomes. F2 -IsoP and IsoF levels could be useful biomarkers for determining the suitability of blood components for transfusion. A novel finding is that cell-free Hb inhibits PLT spreading and could adversely influence wound healing. Poststorage RBC washing minimizes harmful lipid mediators, and its use could potentially reduce transfusion complications.
BACKGROUND: Stored red blood cells (RBCs) release hemoglobin (Hb) that leads to oxidative damage, which may contribute to thrombosis in susceptible transfusion recipients. Oxidative stress stimulates the generation of a new class of lipid mediators called F2 -isoprostanes (F2 -IsoPs) and isofurans (IsoFs) that influence cellular behavior. This study investigated RBC-derived F2 -IsoPs and IsoFs during storage and their influence on human platelets (PLTs). STUDY DESIGN AND METHODS: F2 -IsoP and IsoF levels in RBC supernatants were measured by mass spectrometry during storage and after washing. The effects of stored supernatants, cell-free Hb, or a key F2 -IsoP, 8-iso-prostaglandin F2α (PGF2α ), on PLT function were examined in vitro. RESULTS:F2 -IsoPs, IsoFs, and Hb accumulated in stored RBC supernatants. Prestorage leukoreduction reduced supernatant F2 -IsoPs and IsoFs levels, which increased again over storage time. Stored RBC supernatants and 8-iso-PGF2α induced PLT activation marker CD62P (P-selectin) expression and prothrombotic thromboxane A2 release. Cell-free Hb did not alter PLT mediator release, but did inhibit PLT spreading. Poststorage RBC washing reduced F2 -IsoP and IsoF levels up to 24 hours. CONCLUSIONS:F2 -IsoPs and IsoFs are produced by stored RBCs and induce adverse effects on PLT function in vitro, supporting a potential novel role for bioactive lipids in adverse transfusion outcomes. F2 -IsoP and IsoF levels could be useful biomarkers for determining the suitability of blood components for transfusion. A novel finding is that cell-free Hb inhibits PLT spreading and could adversely influence wound healing. Poststorage RBC washing minimizes harmful lipid mediators, and its use could potentially reduce transfusion complications.
Authors: Joshua P Fessel; Ned A Porter; Kevin P Moore; James R Sheller; L Jackson Roberts Journal: Proc Natl Acad Sci U S A Date: 2002-12-13 Impact factor: 11.205
Authors: Marion Dietrich; Gladys Block; Mark Hudes; Jason D Morrow; Edward P Norkus; Maret G Traber; Carroll E Cross; Lester Packer Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-01 Impact factor: 4.254
Authors: Joost A van Hilten; Leo M G van de Watering; J Hajo van Bockel; Cornelis J H van de Velde; Job Kievit; Ronald Brand; Wilbert B van den Hout; Robert H Geelkerken; Rudi M H Roumen; Ronald M J Wesselink; Ankie W M M Koopman-van Gemert; Jan Koning; Anneke Brand Journal: BMJ Date: 2004-05-13
Authors: Sunil V Rao; James G Jollis; Robert A Harrington; Christopher B Granger; L Kristin Newby; Paul W Armstrong; David J Moliterno; Lauren Lindblad; Karen Pieper; Eric J Topol; Jonathan S Stamler; Robert M Califf Journal: JAMA Date: 2004-10-06 Impact factor: 56.272
Authors: Thomas J van 't Erve; Claire M Doskey; Brett A Wagner; John R Hess; Benjamin W Darbro; Kelli K Ryckman; Jeffrey C Murray; Thomas J Raife; Garry R Buettner Journal: Free Radic Biol Med Date: 2014-08-07 Impact factor: 7.376
Authors: Katherine Plewes; Hugh W F Kingston; Aniruddha Ghose; Richard J Maude; M Trent Herdman; Stije J Leopold; Haruhiko Ishioka; Md Mahtab Uddin Hasan; Md Shafiul Haider; Shamsul Alam; Kim A Piera; Prakaykaew Charunwatthana; Kamolrat Silamut; Tsin W Yeo; Md Abul Faiz; Sue J Lee; Mavuto Mukaka; Gareth D H Turner; Nicholas M Anstey; L Jackson Roberts; Nicholas J White; Nicholas P J Day; Md Amir Hossain; Arjen M Dondorp Journal: BMC Infect Dis Date: 2017-04-27 Impact factor: 3.090
Authors: Mathijs R Wirtz; Jordy Jurgens; Coert J Zuurbier; Joris J T H Roelofs; Philip C Spinella; Jennifer A Muszynski; J Carel Goslings; Nicole P Juffermans Journal: Transfusion Date: 2018-11-21 Impact factor: 3.157